4Brownn J, Madit N, Cole E T et al, 1998. The effect of cross-linking on the in vivo disintegration of hard gelatin capsules. Pharm Res, 1(7): 15.
5Digenis G A, Gold T B, Shah V E 1994. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. Pharm Sci, 1(7): 83.
6Irene Chiwele, Brian E Jones, Fridrun Podczeck, 2000. The shell dissolution of various empty hard capsules. Chem Pharm Bull, 48(7): 951--956.
7Honkanen O, Marvola J, Kanerva H et al, 2004. Gamma scinti- graphic evaluation of the fate of hydroxypropyl methylcel- lulose capsules in the human gastrointestinal tract. European Journal of Pharmaceutical Sciences, 21:671-678.
8Honkanen O, Pia L, Marvola Jet al, 2002. Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl me- thylcellulose capsule formulations and corresponding gelatin capsule formulations. European Journal of Pharmaceutical Sciences, 15:479-488.
9Tuleu C, Basit A W, Waddington W A et al, 2002. Colonic deliv- ery of 4-aminosalicylic acid using amylase-ethylcellulose- coated hydroxypropylmethylcellulose capsules. Aliment Pharmacol Ther, 16:1771-1779.
10Tuleu C, Khela M K, Evans D F et al, 2007. A scintigraphic in- vestigation of the disintegration behavior of capsules in fasting subjects: A comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gela- tion capsules. European Journal of Pharmaceutical Sciences, 30:251-255.
